FOR PHYSICIAN-OWNERS OF GROUP PRACTICES
Private equity has been acquiring physician-owned practices through MSO (Management Services Organization) structures for over a decade. The volume is real, the multiples are real, and the diligence is sophisticated. What separates the practices that transact at the top of the multiple range from the practices that take depressed offers or no offer at all is not luck. It comes down to a small set of operational and structural dimensions that PE-backed healthcare acquirers underwrite with precision.
THE PATTERN
The founding physician (or two founding partners) still produces 50–60% of clinical revenue. The associate physicians are competent some have been with the group five-plus years but production per associate sits meaningfully below the founding partner's per-day numbers. The group has accepted this as normal.
Two associate physicians have left in the last three years, each taking some patient relationships with them. The exits were "lifestyle decisions" but you suspect compensation structure and growth opportunity contributed. You haven't materially changed the structure since.
The practice has been approached by a PE-backed healthcare platform or by a regional consolidator, or by a multi-specialty group looking to acquire at least once in the last 24 months. The conversation didn't progress. You're not sure whether the offer was below market or whether the practice wasn't yet positioned to be valued accurately.
The back office runs on a long-tenured practice administrator who is excellent at her job and entirely irreplaceable in her current configuration. You know this is a problem. You haven't built the redundancy that would address it.
Financial reporting is prepared by an outside CPA for tax filing. There's no monthly management reporting cadence with per-physician productivity, per-location margin (if multi-location), per-service-line profitability, or per-payer-mix analysis. The numbers PE acquirers underwrite to are not the numbers you currently produce internally.
You're not certain whether the right path is PE-backed acquisition through an MSO structure, transition to incoming associate-partners, sale to a hospital system or larger physician group, or hold and continue building. The question doesn't get answered because the practice isn't yet positioned to be evaluated against any of those paths cleanly.
This is fixable. The work is structured. The timeline is 18–24 months.
THE UNDERWRITING MODEL
The PE-backed healthcare consolidation landscape includes specialty-focused platforms (ophthalmology, dermatology, orthopedics, dental, urology, gastroenterology, women's health, and others), multi-specialty consolidators, and hospital-system-affiliated acquirers. Each operates with sophisticated, repeatable underwriting models. The questions they ask in diligence are not creative they're the same questions in every transaction in the category.
Revenue per physician day, RVUs per physician, procedure volumes per associate, ancillary revenue per provider. PE-backed platforms have specialty-specific benchmarks and they underwrite the practice against those benchmarks. A practice running at 70% of top-quartile productivity is meaningfully discounted.
What's the commercial vs. government payer mix? What's the concentration with the largest commercial payer? Are payer contracts in good standing with terms favorable to the practice? Specialty practices with strong commercial mix and diversified payer relationships trade at premium multiples. Practices with concentrated payer exposure or unfavorable contract terms are discounted accordingly.
PE acquirers underwrite the risk of associate departures post-close. Practices with documented compensation structures benchmarked to specialty top-quartile, with formal partnership tracks, with documented retention agreements that survive a transaction, command premium multiples. Practices without this discipline are either discounted or required to put founder retention in place post-close to protect against associate flight.
What happens to clinical revenue when the founding physician's clinical hours go to zero (or to a lifestyle level) post-close? A practice where the founder produces 50%+ of revenue requires extended founder-physician retention with substantial earnout. A practice where the founder produces under 25% trades cleanly with a short transition window.
Imaging, lab, pathology, surgical center participation, infusion services, ambulatory surgery ancillary revenue is often the highest-margin part of a specialty practice and a significant value driver in PE consolidation. Practices with developed ancillary revenue trade at meaningfully higher multiples than pure professional-service practices.
For multi-location groups, the question is whether the locations operate to a consistent standard. Standardized groups trade at premium multiples per location. Non-standardized groups are valued as N separate practices with overhead.
EHR optimization, patient portal adoption, AI-augmented documentation and coding, automated prior authorization, AI-driven patient scheduling and communication. Healthcare acquirers are increasingly factoring modernization into their underwriting. A practice on outdated technology infrastructure is discounted regardless of clinical excellence.
Clean malpractice history. Documented compliance program. Clean coding and billing audit trail. Properly structured employment and independent-contractor relationships. Acquirers spend significant diligence resources here, and unresolved compliance issues are deal-killers, not just multiple-reducers.
WHAT FOUNDING PHYSICIANS RARELY SEE
Three patterns appear in nearly every founder-led group practice we work with. They look like normal operational tradeoffs from inside the practice. They look like underwriting risk from inside the PE acquirer's diligence team.
Every group practice has a clinical reputation, and the reputation is usually attached to the founding physician's name. Patients ask for the founder. Referring physicians refer to the founder personally. Associate physicians defer to the founder on complex cases. The compensation structure for associates almost always sits meaningfully below the founder's effective compensation. When the PE acquirer underwrites the practice, every one of these dynamics translates into post-close risk. The work of decoupling the founder's name from the practice's clinical brand through deliberate associate elevation, structured patient transitions, redistributed referring-physician relationships, and rebalanced compensation takes 12–18 months and is the single largest multiple-expansion lever.
Most founder-led medical practices have one long-tenured practice administrator who runs everything operational. This person is competent, loyal, and entirely irreplaceable in her current configuration. From the PE acquirer's perspective, the administrator-singularity is a structural risk if she leaves, multiple things break at once. The fix is not to replace her. The fix is to systematically document the workflows she runs from memory, redistribute oversight across an operational team, and build the management depth that means her departure (eventually inevitable) doesn't break the practice. Takes 12 months. Often resisted because the administrator has been loyal for decades and the founder is uncomfortable suggesting redundancy is needed.
Most physician-owned practices have less rigorous internal financial reporting than the medical practices they admire. Physician compensation runs through several categories. Family members may be on payroll in administrative roles. Ancillary revenue is often understated in tax filings. When the PE acquirer asks for normalized EBITDA, the practice has to spend several months reconstructing what should have been clear monthly all along. Every reconstructed add-back is friction in diligence and a potential multiple reduction.
THE METHOD APPLIED TO MEDICAL
Diagnostic against PE-backed healthcare underwriting. Per-provider productivity benchmarked against specialty top-quartile. Payer mix and concentration analyzed. Associate retention risk assessed. Founder-physician dependency quantified. Ancillary revenue analysis. Multi-location operational consistency mapped (for groups). AI Maturity Scorecard. Baseline valuation range against current PE-backed specialty consolidation multiples.
Practice-wide vision and three-year clinical and strategic plan. Accountability chart with operational and clinical leadership clearly delineated practice administrator function structured for redundancy, location-level operational ownership defined, clinical leadership defined separately from operational leadership. Core SOPs documented: scheduling, intake, clinical workflow, billing and coding, ancillary services workflow, patient communication, physician-onboarding. Financial discipline upgraded with monthly management reporting, normalized physician compensation, per-location and per-service-line P&L visibility.
Operating cadence installed weekly clinical-and-operational leadership meeting, monthly all-physicians business meeting, quarterly planning. Scorecards built and tracked: per-provider productivity, ancillary revenue mix, payer mix, denial and collection cycle, patient satisfaction metrics, AI workflow utilization metrics. Individual development plans for senior associates on the partnership track. Performance review cadence. AI Operations Playbook for documentation, coding, prior authorization, and patient communication workflows.
Ancillary revenue optimization across all locations. Payer contract review and renegotiation where appropriate. Service-line profitability analysis. Provider compensation structures reviewed and benchmarked. Associate compensation rebalanced to top-quartile with structured partnership tracks. AI-enhanced service offerings developed (typically in patient experience, scheduling, and communication).
Founder-physician's clinical hours systematically reduced to lifestyle-target levels. Practice-wide clinical leadership distributed across senior associates. Operational decision-making fully delegated to the redundant operational structure built in Phases 2–3. Patient relationships systematically transferred. Comprehensive associate retention agreements with appropriate non-competes and non-solicits structured to survive a transaction.
Three years of reviewed financials with full normalization of physician compensation. Complete contract audit (physician employment agreements, associate compensation contracts, payer contracts, lease, vendor relationships, malpractice coverage, ancillary service agreements). Compliance program documented. EHR, technology stack, and AI workflow documentation. Full virtual data room organized to PE-backed healthcare standard. Mock due diligence pass against representative PE platform underwriting model. Exit Readiness Certificate issued.
MSO structure design, corporate-practice-of-medicine compliance, anti-kickback analysis, Stark Law structuring, and the specific legal architecture of the transaction itself require specialist healthcare counsel. TANDM coordinates with your legal team but does not provide legal advice. Where you do not yet have specialist healthcare M&A counsel, we can recommend qualified firms.
THE ARITHMETIC
Multiples in PE-backed specialty consolidation vary by specialty, geography, and structure but the range typically spans from approximately 4x adjusted EBITDA at the unprepared end to 9x or higher for premium-prepared groups in attractive specialties. A representative example:
Today
BeforeFounder producing 50%+ of revenue. Two associates departed in last 3 years. Ancillary revenue at 12% of total. Practice administrator irreplaceable. Mandatory founder retention 5+ years post-close with substantial earnout.
After Exit-Ready Method™
AfterFounder at 28% of revenue, lifestyle hours by choice. Associate retention discipline documented. Ancillary revenue at 19% of total. Administrator function redundant. Three years of reviewed financials. EHR and AI workflow documentation in data room. Founder retention de-coupled from deal economics.
That's roughly $10M–$13M+ in additional enterprise value on the same group. Same patients. Same locations. Same brand. Different multiple because the practice was built to be transacted on.
WORKING TOGETHER
$15K–$25K
Fixed fee · 6–8 weeks
$3K–$5K/month
Group program · 6 months
8–12 founders per cohort. Bi-weekly group sessions, monthly 1-on-1 hot seats, templates and frameworks.
Best for founders who want structure and peer accountability.
$8K–$15K/month
Private advisory · 12–16 months
Dedicated TANDM Jumpmaster. Phases 2–5 implementation. AI integration throughout. Two days per month on-site or virtual plus weekly calls.
Best for most growing businesses $3M–$10M.
$12K–$20K/month
Complete methodology · 18–24 months
All six phases. Data room and mock due diligence. CIM and go-to-market prep. AI due diligence package. Exit-Ready Certified™ standard.
Best for owners preparing to transact within 24–36 months.
Whether you're planning a PE-backed MSO transaction, a transition to incoming associate-partners, a hospital-system affiliation, or just want a practice that runs without the founder physician at chairside every day, the operational and structural preparation is the same. Start with the diagnostic.